Efficacy and safety of FOLFIRINOX in elderly patients with advanced pancreatic adenocarcinoma.

被引:0
|
作者
Jung, Jae Hyup
Kang, Jingu
Lee, Jong-Chan
Hwang, Jin-Hyeok
机构
[1] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[2] Hallym Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
关键词
D O I
10.1200/JCO.2019.37.15_suppl.e15729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15729
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer
    Shindo, Yoshitaro
    Ioka, Tatsuya
    Tokumitsu, Yukio
    Matsui, Hiroto
    Nakajima, Masao
    Kimura, Yuta
    Watanabe, Yusaku
    Tomochika, Shinobu
    Nakagami, Yuki
    Tsunedomi, Ryouichi
    Iida, Michihisa
    Takahashi, Hidenori
    Nagano, Hiroaki
    CANCERS, 2024, 16 (14)
  • [42] Experience with FOLFIRINOX regimen in patients over 65 years old diagnosed with pancreatic adenocarcinoma: Efficacy and safety data.
    Gomes, Jessica Ribeiro
    Tsukamoto, Jessica Sayuri
    Alessandretti, Matheus Bongers
    D'Alpino, Renata D'Alpino
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
    Yoo, Changhoon
    Hwang, Inhwan
    Song, Tae Jun
    Lee, Sang Soo
    Jeong, Jae Ho
    Park, Do Hyun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Byun, Jae Ho
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Chang, Heung-Moon
    Kim, Kyu-pyo
    Kim, Song Cheol
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [44] Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma
    Ulusakarya, Ayhan
    Teyar, Nahla
    Karaboue, Abdoulaye
    Haydar, Mazen
    Krimi, Sarra
    Biondani, Pamela
    Gumus, Yusuf
    Chebib, Amale
    Almohamad, Wathek
    Morere, Jean-Francois
    MEDICINE, 2019, 98 (16)
  • [45] Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinoma
    Pignon, Flore
    Turpin, Anthony
    Hentic, Olivia
    Coriat, Romain
    Salmon, Emma
    Baumgaertner, Isabelle
    Bertrand, Nicolas
    Levy, Philippe
    Rebours, Vinciane
    Hammel, Pascal
    de Mestier, Louis
    PANCREATOLOGY, 2021, 21 (06) : 1064 - 1070
  • [46] Safety and efficacy of bevacizumab (By) in elderly patients with NSCLC adenocarcinoma
    Syrigos, K.
    Vassos, D.
    Panagiotarakou, M.
    Tsoukalas, G.
    Athanasiadis, G.
    Sepsas, E.
    Tsimboukis, S.
    Moutsos, M.
    Charpidou, A.
    Kaltsas, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S342 - S342
  • [47] Tolerability and clinical outcomes in elderly patients with advanced pancreatic cancer treated with FOLFIRINOX.
    Yamamoto, Taikan
    Sunakawa, Yu
    Kubota, Yutaro
    Tagawa, Teppei
    Kaga, Yasuhiro
    Ikusue, Toshikazu
    Uto, Yu
    Kitahara, Yu
    Toshima, Hirokazu
    Kobayashi, Kouji
    Hisamatsu, Atsushi
    Ichikawa, Wataru
    Sekikawa, Takashi
    Shimada, Ken
    Sasaki, Yasutsuna
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [48] Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX
    Fonseca de Jesus, Victor Hugo
    Guedes Camandaroba, Marcos Pedro
    Spina Donadio, Mauro Daniel
    Cabral, Audrey
    Muniz, Thiago Pimentel
    Leite, Luciana de Moura
    Sant'Ana, Lucas Ferreira
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (05) : 806 - 819
  • [49] Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
    Lakatos, G.
    Petranyi, A.
    Szucs, A.
    Nehez, L.
    Harsanyi, L.
    Hegyi, P.
    Bodoky, G.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 753 - 759
  • [50] Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
    Yoo, Changhoon
    Kang, Jihoon
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Park, Jin-Hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Kim, Song Cheol
    ONCOTARGET, 2017, 8 (28) : 46337 - 46347